Research and development - Press Releases

Date	Title	Company
08-Jan-2025	"Annotatability" is a New Method to Decode How AI Learns to Label Developed by Hebrew University Researchers	Hebrew University of Jerusalem
08-Jan-2025	Commit Biologics appoints accomplished R&D executive, Dr Janine Schuurman, to its Board of Directors	Commit Biologics
07-Jan-2025	Transplantable piezoelectric biomaterial offers new treatment potential for central nervous system injuries and neurodegenerative diseases	University of Bath
02-Jan-2025	New study reveals that sleep prevents unwanted memories from intruding	University of East Anglia
02-Jan-2025	Ancient DNA unlocks new understanding of migrations in the first millennium AD	Francis Crick Institute
29-Dec-2024	New GCP Training with Certificate	Pharma Lessons
26-Dec-2024	Alfa Chemistry Spreads Holiday Cheer, Offering Exclusive Discounts and Festive Gifts	Alfa Chemistry
20-Dec-2024	Precision oncology company Sentinal4D completes pre-seed funding round and launches to the public	The Institute of Cancer Research
20-Dec-2024	Accelerating and enhancing toxicology assessments	Broughton
20-Dec-2024	Epitopea and Genevant Sciences Announce Collaboration Agreement	Epitopea
19-Dec-2024	Building a backbone: scientists recreate the body’s ‘GPS system’ in the lab	Francis Crick Institute
19-Dec-2024	Protheragen-ING Releases Hundreds of APIs: Anti-Tumor APIs, Hypoglycemic APIs, Antipsychotic APIs, Bronchiectasis APIs, Antihypertensive APIs	Protheragen-ING
19-Dec-2024	Protheragen-ING Lab Launches Comprehensive Pharmaceutical Safety Evaluation Services	Protheragen-ING
19-Dec-2024	CD Formulation Announces Festive Discounts: 5%-15% Off on All Products and Services	CD Formulation
19-Dec-2024	CD Formulation Reveals Specialty in Oral Thin Film Manufacturing Technologies	CD Formulation
19-Dec-2024	Alfa Chemistry Expands Pharmaceutical Product Portfolio: Introducing PROTAC Building Blocks, Nucleosides, Intermediates, and APIs	Alfa Chemistry
19-Dec-2024	Alfa Chemistry Demonstrates Expertise in Research, Development and Manufacture of Multiple Sputtering Targets	Alfa Chemistry
18-Dec-2024	Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics	Orion
17-Dec-2024	Terumo Blood and Cell Technologies Presents Data on Automated Red Blood Cell Exchange to Treat Sickle Cell Disease at the American Society of Hematology	Terumo Blood and Cell Technologies
17-Dec-2024	New OHE research finds productivity losses from respiratory infections cost UK businesses £44 billion per year	OHE